ALT
Price
$5.96
Change
+$0.34 (+6.05%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
455.82M
59 days until earnings call
CRNX
Price
$32.27
Change
-$0.74 (-2.24%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
3.09B
60 days until earnings call
Interact to see
Advertisement

ALT vs CRNX

Header iconALT vs CRNX Comparison
Open Charts ALT vs CRNXBanner chart's image
Altimmune
Price$5.96
Change+$0.34 (+6.05%)
Volume$120.55K
Capitalization455.82M
Crinetics Pharmaceuticals
Price$32.27
Change-$0.74 (-2.24%)
Volume$9.19K
Capitalization3.09B
ALT vs CRNX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. CRNX commentary
Jun 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and CRNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2025
Stock price -- (ALT: $5.49 vs. CRNX: $29.91)
Brand notoriety: ALT and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 64% vs. CRNX: 90%
Market capitalization -- ALT: $455.82M vs. CRNX: $3.09B
ALT [@Biotechnology] is valued at $455.82M. CRNX’s [@Biotechnology] market capitalization is $3.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALT is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while CRNX’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 6 bearish.
  • CRNX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ALT and CRNX are a bad buy in the short-term.

Price Growth

ALT (@Biotechnology) experienced а -1.79% price change this week, while CRNX (@Biotechnology) price change was -0.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.00%. For the same industry, the average monthly price growth was +19.89%, and the average quarterly price growth was +5.86%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.09B) has a higher market cap than ALT($456M). ALT YTD gains are higher at: -23.856 vs. CRNX (-41.502). ALT has higher annual earnings (EBITDA): -94.81M vs. CRNX (-336.07M). CRNX has more cash in the bank: 1.35B vs. ALT (132M). ALT has less debt than CRNX: ALT (1.68M) vs CRNX (51.7M). CRNX has higher revenues than ALT: CRNX (1.04M) vs ALT (20K).
ALTCRNXALT / CRNX
Capitalization456M3.09B15%
EBITDA-94.81M-336.07M28%
Gain YTD-23.856-41.50257%
P/E RatioN/AN/A-
Revenue20K1.04M2%
Total Cash132M1.35B10%
Total Debt1.68M51.7M3%
FUNDAMENTALS RATINGS
ALT vs CRNX: Fundamental Ratings
ALT
CRNX
OUTLOOK RATING
1..100
5565
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
9068
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6286
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRNX's Valuation (92) in the Pharmaceuticals Major industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that CRNX’s stock grew similarly to ALT’s over the last 12 months.

CRNX's Profit vs Risk Rating (68) in the Pharmaceuticals Major industry is in the same range as ALT (90) in the Miscellaneous Commercial Services industry. This means that CRNX’s stock grew similarly to ALT’s over the last 12 months.

CRNX's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that CRNX’s stock grew similarly to ALT’s over the last 12 months.

ALT's Price Growth Rating (62) in the Miscellaneous Commercial Services industry is in the same range as CRNX (86) in the Pharmaceuticals Major industry. This means that ALT’s stock grew similarly to CRNX’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that ALT’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTCRNX
RSI
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
82%
Bullish Trend 13 days ago
82%
Momentum
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
84%
MACD
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 13 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
86%
Bearish Trend 13 days ago
77%
Advances
ODDS (%)
Bullish Trend about 1 month ago
83%
Bullish Trend about 1 month ago
77%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 14 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 13 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-0.36%
CRNX - ALT
50%
Loosely correlated
+1.39%
XNCR - ALT
47%
Loosely correlated
-2.58%
COGT - ALT
46%
Loosely correlated
N/A
VKTX - ALT
46%
Loosely correlated
-0.18%
CLDX - ALT
46%
Loosely correlated
-5.66%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.39%
XNCR - CRNX
58%
Loosely correlated
-2.58%
IDYA - CRNX
56%
Loosely correlated
+0.72%
DYN - CRNX
56%
Loosely correlated
+0.51%
TRDA - CRNX
56%
Loosely correlated
+0.91%
RVMD - CRNX
55%
Loosely correlated
+2.04%
More